GSK said Chief Executive Emma Walmsley would step down and be succeeded by commercial chief Luke Miels, as the drugmaker works to replenish its product lineup. Walmsley will step down at the end of ...

GSK experienced an eventful 2022. The British drugmaker officially spun out its consumer health joint venture with Pfizer. And the company’s flagship vaccines business appears to be on the mend. But ...

(Reuters) -GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on Monday, a surprise switch as the British firm looks to rev up its ...

GSK has had a solid start to 2026, with revenues rising ahead of analyst expectations in the first full quarter under new chief executive Luke Miels. The group posted a 2% rise in revenues to $7.6 ...

GSK named Luke Miels to succeed Emma Walmsley as the British drugmaker's chief executive at a pivotal time for the company. Under Walmsley, the U.K. pharmaceuticals giant reinvigorated its research ...